PLRZ
Polyrizon Ltd. Ordinary Shares
NASDAQ: PLRZ · HEALTHCARE · BIOTECHNOLOGY
$14.00
-0.99% today
Updated 2026-05-06
Market cap
$29.95M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.90
Dividend yield
—
52W range
$3 – $2,235
Volume
0.0M
Polyrizon Ltd. Ordinary Shares (PLRZ) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — |
| Cost of revenue | $1000.00 | $6000.00 | $5000.00 | $4000.00 | $118000.00 | $342000.00 |
| Gross profit | $-1000.00 | $-6000.00 | $-5000.00 | $-4000.00 | $-118000.00 | $-342000.00 |
| Gross margin | — | — | — | — | — | — |
| R&D | $38000.00 | $245000.00 | $347000.00 | $332000.00 | $534000.00 | $2.13M |
| SG&A | $34000.00 | $458000.00 | $533000.00 | $303000.00 | $768000.00 | $3.65M |
| Operating income | $-72000.00 | $-703000.00 | $-895000.00 | $-635000.00 | $-1.30M | $-6.25M |
| Operating margin | — | — | — | — | — | — |
| EBITDA | $-72000.00 | $-703000.00 | $-772000.00 | $-631000.00 | $-1.42M | $-5.91M |
| EBITDA margin | — | — | — | — | — | — |
| EBIT | $-73000.00 | $-709000.00 | $-777000.00 | $-635000.00 | $-1.54M | $-6.25M |
| Interest expense | — | $2000.00 | $2000.00 | $2000.00 | $3000.00 | $3.14M |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-73000.00 | $-711000.00 | $-779000.00 | $-600000.00 | $-1.54M | $-3.33M |
| Net income growth (YoY) | — | -874.0% | -9.6% | +23.0% | -157.5% | -115.9% |
| Profit margin | — | — | — | — | — | — |